Avexitide

N/A

Report date: 2026/04/14 20:00:15
NMEFirst In Class

Base Information

Drug NameAvexitide
Drug Alias NameExendin (9-39)amideAvexitide acetateExendin 9Exendin 9-39 acetateExendin-(9-39) +[8] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor antagonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsPost-bariatric HypoglycemiaHypoglycemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesEiger Biopharmaceuticals IncAmylyx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPost-bariatric HypoglycemiaHypoglycemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A